News

SAN FRANCISCO – Guardant Health has announced a 31% increase in revenue, reaching $737 million in its preliminary 2024 earnings...

A serendipitous discovery that would go on to revolutionize treatments for heart disease and impotence took place decades ago in...

A group of prominent medical professionals, including leading infectious diseases expert Professor Yuen Kwok-yung, has called on Hong Kong's finance...

China is currently experiencing a higher rate of influenza compared to earlier in the year, but the numbers are still...

False claims about a "health emergency" in China, supposedly triggered by a viral outbreak, have been circulating on social media,...

Ruxolitinib cream, a topical Janus kinase (JAK) 1/2 inhibitor, has shown promising results in treating pediatric patients with moderate to...

France's health authorities have introduced a new, more effective shingles vaccine, Shingrix, as part of its official vaccination program, following...

Jasper Therapeutics Reports Positive Data in Chronic Urticaria StudyJasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company valued at $266 million,...

A recent study published in JAMA Dermatology sheds light on the experiences of Latine individuals living with moderate to severe...

The global prevalence of atopic dermatitis among children is expected to rise significantly over the next five decades, according to...